Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesClinical/Medical PolicyHealth New England Medical Necessity Update | Open…
    Ask Trek AI about this page
    CurrentHealth-New-EnglandPolicy UM407POL

    Medical Necessity and Experimental and Investigational - Medical Policy

    Customize your policy alerts

    Sign up for Health-New-England Policy UM407POL alerts

    Get alerted when Policy UM407POL changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy defines how Health New England evaluates medical necessity, lack of medical necessity, and experimental or investigational status for healthcare services, procedures, technologies, devices, biologics, and drug therapies. It applies to Commercial, Medicare Advantage, and Medicaid (BeHealthy) lines of business and supports prior-authorization review.

    Policy Summary
    PayerHealth-New-England
    PolicyMedical Necessity and Experimental and Investigational - Medical Policy
    Policy CodePolicy UM407POL
    Change TypeMaterial Revision
    Effective DateSeptember 1, 2026
    Next Review DateN/A
    Key ActionThe treating physician or primary care provider must submit clinical evidence that the patient meets the criteria for the requested treatment, testing, or surgical procedure.
    SourceLink
    POLICY UPDATE CHANGES

    The experimental and investigational definition was revised in June 2025.

    The Medicaid definition of medical necessity was updated in 2025.

    InterQual CP: Procedures criteria were added to the experimental and investigational policy guidelines in June 2025.

    Minor updates were made to the policy guidelines in May 2026.

    3Applicable lines of business
    5

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Core medical-necessity requirements for standard HNE review
    11Clinical and external review resources listed
    Category IIICategory III services generally considered experimental
    Prior authorizationClinical documentation required

    Medical Necessity and Experimental & Investigational Criteria

    Standard Medical Necessity

    A service is medically necessary only when ALL of the following are met.

    Standard Health New England medical necessity

    • Clinical appropriateness and effectiveness: The service is clinically appropriate regarding type, frequency, extent, site, and duration, and is considered effective for the patient's illness, injury, or disease.
    • Evidence basis: The service is based on credible scientific evidence published in peer-reviewed medical literature recognized by the relevant medical community, specialty society recommendations, or the views of physician experts practicing in the relevant clinical area.

      At least one listed evidence source must support the service.

    • Cost-effectiveness: The service is not more costly than an alternative service or sequence of services that is at least as likely to produce equivalent therapeutic or diagnostic results.
    • Not primarily for convenience: The service is not primarily for the convenience of the patient, physician, or other healthcare provider.
    • Clinical-record support: The service is substantiated by submitted clinical records.

    MassHealth Medical Necessity

    For MassHealth, medically necessary services must satisfy ALL of the following requirements.

    MassHealth medical necessity

    • Clinical purpose and functional need: The service is reasonably calculated to prevent, diagnose, prevent worsening of, alleviate, correct, or cure a condition that endangers life, causes suffering or pain, causes physical deformity or malfunction, threatens or aggravates a handicap, or results in illness or infirmity; achieves age-appropriate growth and development; or attains, maintains, or regains functional capacity.
    • No suitable less costly comparable service: There is no other medical service or site of service comparable in effect that is available and suitable and more conservative or less costly to the MassHealth agency.

      Potential alternative sources of healthcare may be considered under the cited MassHealth regulations.

    • Quality and documentation: The service is of a quality that meets professionally recognized standards of healthcare and is substantiated by records including evidence of medical necessity and quality.

    CMS Medical Necessity

    CMS medically necessary services or supplies must meet ALL of the following requirements.

    CMS medical necessity: The service or supply is proper and needed for diagnosis, direct care, or treatment of the medical condition, meets standards of good medical practice in the local area, and is not mainly for the convenience of the patient or provider.

    Not Medically Necessary

    A service is not medically necessary when the evidence basis exists but ANY of the following applies.

    Not medically necessary

    • Clinical appropriateness failure: The service is not clinically appropriate in type, frequency, extent, site, or duration, or is not considered effective for the patient's illness, injury, or disease.
    • Higher-cost equivalent alternative: The service is more costly than an alternative service or sequence of services at least as likely to produce equivalent therapeutic or diagnostic results.
    • Convenience service: The service is primarily for the convenience of the patient, physician, or other healthcare provider.

    Experimental and Investigational

    A service may be classified as experimental and investigational when ANY of the listed conditions applies.

    Experimental and investigational

    • Insufficient evidence or endorsement: Safety and effectiveness for the proposed use have not been demonstrated through credible peer-reviewed evidence or strong specialty-society recommendations.
    • No applicable regulatory approval: The service or technology has not been approved by the FDA or another appropriate regulatory agency for lawful marketing for the proposed use.
    • Institutional Review Board involvement: The service or technology has been subject to review or approval by an Institutional Review Board for the proposed use.

    A service, procedure, or device determined by the Medical and Pharmacy Policy Committee to be experimental, unproven, or investigational is not eligible for payment. The Committee evaluates healthcare technologies, pharmaceuticals, devices, and medical, surgical, and behavioral health services using evidence-based information, including established peer-reviewed scientific data.

    Category III services are temporary codes used to describe emerging technologies, services, and procedures and to support data collection and evaluation of clinical efficacy. Unless covered under a separate medical policy or through mandated coverage, Category III services are considered experimental and investigational.

    Services are not medically necessary when they are not clinically appropriate or effective for the patient's illness, injury, or disease; are more costly than an alternative service or sequence of services that is at least as likely to produce equivalent therapeutic or diagnostic results; or are primarily for the convenience of the patient, physician, or other healthcare provider.

    Prior Authorization and Documentation Requirements

    Prior Authorization

    Prior Authorization Documentation Required

    The treating physician or primary care provider must submit documentation and clinical evidence showing that the patient meets the criteria for the requested treatment, testing, or surgical procedure. Without this information, Health New England cannot properly review the prior-authorization request.

    Documentation Required

    Submit Clinical Evidence

    Submit clinical records and supporting evidence substantiating that the applicable medical-necessity criteria are met, including evidence relevant to the service’s clinical appropriateness, effectiveness, and supporting clinical standards.

    • Include relevant medical records and evidence supporting the requested treatment, testing, or procedure.
    • Use applicable HNE clinical review criteria and supporting evidence from recognized clinical sources.

    Policy Purpose and Scope

    Health New England evaluates services based on clinical appropriateness and effectiveness, credible evidence and relevant specialty-society or physician-expert support, and whether the service is cost-effective compared with an equivalent alternative. Reviews may use evidence-based clinical criteria and applicable Medicare or Medicaid coverage policies. Services must also be supported by clinical records; for MassHealth, the service must meet recognized quality standards and have no suitable, comparable, more conservative, or less costly alternative.

    Key Policy Definitions

    Medically Necessary
    DefinitionServices reasonably calculated by a provider to prevent, diagnose, evaluate, or treat illness, injury, or disease.
    Clinical appropriateness and effectivenessThe service is clinically appropriate in type, frequency, extent, site, and duration, and is considered effective for the patient’s illness, injury, or disease.
    Evidence basisThe service is based on credible scientific evidence published in peer-reviewed medical literature recognized by the relevant medical community, specialty-society recommendations, or the views of physician experts practicing in the relevant clinical area.
    Cost and convenienceThe service is not more costly than an alternative service or sequence of services at least as likely to produce equivalent therapeutic or diagnostic results, and is not primarily for the convenience of the patient, physician, or other health care provider.
    DocumentationThe service is substantiated by submitted clinical records.
    Policy Summary
    PayerHealth-New-England
    PolicyMedical Necessity and Experimental and Investigational - Medical Policy
    Policy CodePolicy UM407POL
    Change TypeMaterial Revision
    Effective DateSeptember 1, 2026
    Next Review DateN/A
    Key ActionThe treating physician or primary care provider must submit clinical evidence that the patient meets the criteria for the requested treatment, testing, or surgical procedure.
    SourceLink
    On This Page
    Medical Necessity and Experimental & Investigational CriteriaPrior Authorization and Documentation RequirementsPolicy Purpose and ScopeKey Policy Definitions

    Providers must make the records available to MassHealth upon request.

    Documentation Required

    Maintain MassHealth Records

    For MassHealth members, maintain records demonstrating medical necessity and the quality of the service. Providers must make these records, including medical records and supporting evidence, available to the MassHealth agency upon request.

    • Records must substantiate both medical necessity and professionally recognized quality of care.
    • MassHealth-deemed non-payable codes may be reviewed for medical necessity for members under age 21 at a provider’s request.
    Denial Risk

    Failure to Meet Medical-Necessity Standards

    A service may fail Health New England’s medical-necessity standard when it is not clinically appropriate or effective for the patient’s condition, lacks required supporting evidence, is more costly than an equally effective alternative, is primarily for the convenience of the patient or provider, or is not substantiated by submitted clinical records.

    • The service must be appropriate in type, frequency, extent, site, and duration.
    • The service must be supported by credible peer-reviewed evidence, specialty-society recommendations, or relevant physician-expert views.
    • A less costly alternative or sequence of services must not be at least as likely to produce equivalent therapeutic or diagnostic results.
    • Submitted clinical records must substantiate the request.
    Denial Risk

    Experimental or Investigational Services

    Health New England may classify medical, surgical, diagnostic, psychiatric, substance-use-disorder, or other health-care technologies and related services, procedures, supplies, treatments, devices, biologic products, or drug therapies as experimental and investigational when the proposed use lacks credible evidence of safety and effectiveness, lacks appropriate regulatory approval, or has been subject to Institutional Review Board review or approval.

    • Review applicable HNE non-covered-service information and clinical criteria when evaluating experimental or investigational status.
    • MPPC reviews new technologies, new applications, pharmaceuticals, devices, and medical, surgical, and behavioral-health services and procedures.
    Denial Risk

    Category III Services

    Category III codes describe emerging technologies, services, and procedures and are used for data collection and evaluation. Unless covered under a separate medical policy or by mandated coverage, all Category III services are considered experimental and investigational.

    • Creation of a Category III code by the AMA does not imply or endorse clinical efficacy, safety, or applicability to clinical practice.
    Denial Risk

    No Payment for Experimental or Investigational Services

    When Health New England’s Medical and Pharmacy Policy Committee determines that a service, procedure, or device is experimental, unproven, or investigational, it is not eligible for payment.

    • The payment consequence applies when the MPPC makes the experimental, unproven, or investigational determination.
    Not Medically Necessary
    DefinitionA service supported by credible scientific evidence published in peer-reviewed medical literature recognized by the relevant medical community, specialty-society recommendations, or the views of physician experts practicing in the relevant clinical area.
    Clinical appropriateness or effectivenessThe service is not clinically appropriate in type, frequency, extent, site, or duration, or is not considered effective for the patient’s illness, injury, or disease.
    Higher-cost equivalent alternativeThe service is more costly than an alternative service or sequence of services at least as likely to produce equivalent therapeutic or diagnostic results for the patient’s illness, injury, or disease.
    Convenience serviceThe service is primarily for the convenience of the patient, physician, or other health care provider.
    Experimental and Investigational
    ScopeMedical, surgical, diagnostic, psychiatric, substance use disorder, or other health care technology-related services; procedures, supplies, treatments, devices, biologic products, or drug therapies.
    Insufficient evidence or endorsementThe service or technology has not been demonstrated to be safe and effective for diagnosing or treating the proposed condition or illness through credible scientific evidence published in peer-reviewed medical literature recognized by the relevant medical community, nor strongly endorsed by specialty-society recommendations.
    Regulatory approvalThe service or technology has not been approved by the U.S. Food and Drug Administration or another appropriate regulatory agency to be lawfully marketed for the proposed use.
    Institutional Review Board reviewThe service or technology has been the subject of review or approval by an Institutional Review Board for the proposed use.